The above experiments indicate that inhibition of PGC1α increases CDDP sensitivity and apoptosis sensitivity by reducing mitochondrial biogenesis and energy metabolism in lung cancer cells with dysfunctional p53. Here, PPARGC1A is linked to lung cancer.